Advertisement

Topics

LabCorp strengthens its CRO standing with $1.2B Chiltern acquisition

06:00 EDT 31 Jul 2017 | BioPharmaDive

The deal should expand the buyer's CRO workforce to more than 11,000 employees.

Original Article: LabCorp strengthens its CRO standing with $1.2B Chiltern acquisition

NEXT ARTICLE

More From BioPortfolio on "LabCorp strengthens its CRO standing with $1.2B Chiltern acquisition"

Quick Search
Advertisement
 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...